IPE 📈 Ipopema Securities SA - Overview
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLIPOPM00011
IPE: Investment, Banking, Brokerage, Funds, Securities, Advisory
IPOPEMA Securities S.A. provides brokerage, equity research, and investment banking services in Poland. It operates through Brokerage and Related Services; Investment Fund and Portfolio Management; and Advisory Services segments. The Brokerage and Related Services segment is involved in the brokerage and investment banking activities, distribution of investment products, and provision of investment advisory services to retail investors, as well as advisory services related to corporate financial restructuring and finance raising for infrastructure projects. The Investment Fund Management and Portfolio Management segment engages in the creation and management of investment funds; and the management of portfolios of broker-traded financial instruments. The Advisory Services segment provides business and management advisory, computer facilities management, computer advisory, and software-related activities. The company also offers investment banking services, which include preparation and execution of transactions on the equity capital market, public offerings of securities, mergers, and acquisitions (M&A) transactions and management buy-outs, and advisory services for raising finance on the private market, as well as assists companies listed on the Warsaw Stock Exchange in arranging share repurchase transactions, including tender offers and buyback programs. In addition, it provides business, management, and IT consultancy services; financial restructuring advisory services; securities trading advisory services; and intermediation services. Further, the company is involved in the distribution of investment products; creation and management of closed-end and open-end investment funds; wholesale of computers, peripherals, and equipment and software. IPOPEMA Securities S.A. was founded in 2005 and is based in Warsaw, Poland. Web URL: https://www.ipopemasecurities.pl
Additional Sources for IPE Stock
IPE Stock Overview
Market Cap in USD | 20m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception |
IPE Stock Ratings
Growth 5y | 18.1% |
Fundamental | 42.9% |
Dividend | 29.7% |
Rel. Strength Industry | -207 |
Analysts | - |
Fair Price Momentum | 2.20 PLN |
Fair Price DCF | 19.10 PLN |
IPE Dividends
Dividend Yield 12m | 12.15% |
Yield on Cost 5y | 23.44% |
Annual Growth 5y | -25.99% |
Payout Consistency | 34.2% |
IPE Growth Ratios
Growth Correlation 3m | -94.4% |
Growth Correlation 12m | -89.3% |
Growth Correlation 5y | 25.1% |
CAGR 5y | 13.33% |
CAGR/Mean DD 5y | 0.39 |
Sharpe Ratio 12m | -1.31 |
Alpha | -53.44 |
Beta | 0.71 |
Volatility | 42.72% |
Current Volume | 7.5k |
Average Volume 20d | 5.1k |
What is the price of IPE stocks?
As of December 22, 2024, the stock is trading at PLN 2.36 with a total of 7,508 shares traded.
Over the past week, the price has changed by -4.26%, over one month by -9.52%, over three months by -19.02% and over the past year by -30.67%.
As of December 22, 2024, the stock is trading at PLN 2.36 with a total of 7,508 shares traded.
Over the past week, the price has changed by -4.26%, over one month by -9.52%, over three months by -19.02% and over the past year by -30.67%.
Is Ipopema Securities SA a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Ipopema Securities SA (WAR:IPE) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IPE as of December 2024 is 2.20. This means that IPE is currently overvalued and has a potential downside of -6.78%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ipopema Securities SA (WAR:IPE) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IPE as of December 2024 is 2.20. This means that IPE is currently overvalued and has a potential downside of -6.78%.
Is IPE a buy, sell or hold?
Ipopema Securities SA has no consensus analysts rating.
Ipopema Securities SA has no consensus analysts rating.
What are the forecast for IPE stock price target?
According to ValueRays Forecast Model, IPE Ipopema Securities SA will be worth about 2.4 in December 2025. The stock is currently trading at 2.36. This means that the stock has a potential upside of +2.54%.
According to ValueRays Forecast Model, IPE Ipopema Securities SA will be worth about 2.4 in December 2025. The stock is currently trading at 2.36. This means that the stock has a potential upside of +2.54%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 2.4 | 2.5% |